Zimmer Biomet Faces 14 Cited Observations In FDA Form 483 After Inspection of Indiana Facility
The FDA recently released a Form 483 it issued to Zimmer Biomet after inspecting its Warsaw, Ind.-based facilities, detailing 14 observations during its inspection.
The 58-page document came after the Agency performed a site inspection at the Zimmer Biomet facility from Sept. 12 to Nov. 22 last year, and included some repeat observations from an earlier 2014 inspection.
The full list of observations mentioned in the Form 483 include:
The 58-page document came after the Agency performed a site inspection at the Zimmer Biomet facility from Sept. 12 to Nov. 22 last year, and included some repeat observations from an earlier 2014 inspection.
The full list of observations mentioned in the Form 483 include: